Texas demanda a los fabricantes de Tylenol por supuesto encubrimiento de riesgos de autismonews2025-10-28T16:54:47+00:00October 28th, 2025|The New York Times|
Texas Sues Tylenol Makers, Claiming They Hid Autism Risksnews2025-10-28T12:24:44+00:00October 28th, 2025|The New York Times|
La testosterona devuelve a las mujeres su deseo sexual, pero hay algo másnews2025-10-25T09:01:44+00:00October 25th, 2025|The New York Times|
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Pricesnews2025-10-23T09:00:45+00:00October 23rd, 2025|The New York Times|
How Testosterone Is Giving Middle-Aged Women the Best Sex of Their Livesnews2025-10-22T09:00:59+00:00October 22nd, 2025|The New York Times|
How Private Equity Oversees the Ethics of Drug Researchnews2025-10-04T09:00:13+00:00October 4th, 2025|The New York Times|
Trump May Try to Force Drugmakers to Match European Pricesnews2025-09-26T02:13:57+00:00September 26th, 2025|The New York Times|
F.D.A.’s Approval of a Drug for Autism Upends Review Processnews2025-09-23T23:09:46+00:00September 23rd, 2025|The New York Times|
These Patients Got the Cure. Then It Went Away.news2025-09-22T22:35:25+00:00September 22nd, 2025|The New York Times|
Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertisernews2025-09-12T22:09:11+00:00September 12th, 2025|The New York Times|
